0
0
A recent study has revealed that body fat percentage (BF%) is a more accurate predictor of mortality than the widely used body mass index (BMI), challenging long-standing clinical practices that rely on BMI as the primary measure of obesity and health risk.
Key Findings and Expert Insights
The research, highlighted on Medscape, suggests that while BMI remains the clinical standard, measuring BF% provides a clearer picture of a patient’s health risks related to body composition. Technologies such as DEXA scans and bioelectrical impedance analysis (BIA) machines are used to measure BF%. However, DEXA scanners are expensive—costing between $16,000 and $45,000—while BIA machines range from $129 to nearly $16,000, making widespread adoption a challenge for many practices.
Dr. Ryan Singerman, section chief for Primary Care at Parkview Health in Indiana, noted that clinicians may need to advocate for the use of BIA machines by presenting the study’s findings to practice leadership. He emphasized that not all clinicians are familiar with the latest medical evidence or equipped to make the case for new equipment, but the potential benefits for patient care are significant.
Bariatric surgeon Dr. Kyle J. Thompson pointed out that some patients are becoming more aware of BF% as a health metric and may seek out clinics that offer this analysis. He added that providing BF% assessments could increase referrals and boost demand for related services such as medical weight loss or bariatric surgery.
Challenges and the Path Forward
Despite the promising results, there is currently no consensus on what constitutes a healthy BF%, which complicates its use in routine care. Dr. Thompson highlighted the variability in how BF% results are interpreted and applied in clinical practice, underscoring the need for standardized guidelines.
Experts agree that large, prospective trials are needed to establish validated standards for healthy BF%. Once these standards are in place, BF% measurement using BIA could become the new standard of care. In the meantime, clinicians are encouraged to use BMI alongside BF% measurements to enhance risk assessment and patient management.
“Once these standards are validated, measuring BF% with BIA will then become the standard of care,” said Orlando, one of the study’s authors. “Until then, clinicians can still use BMI alongside BIA in the office to augment risk stratification using published thresholds for healthy body fat percentage.”
Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider with any questions you may have regarding a medical condition or health objectives.
